|

Standard Chemotherapy Clinical Trials

3 actively recruiting trials across 1 location

Pipeline

Phase 2: 1Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Nanfang Hospital, Southern Medical University1
  • Fudan University1
  • Dana-Farber Cancer Institute1

Indications

  • Cancer3
  • Newly Diagnosed Acute Myeloid Leukemia With High Risk1
  • Metastatic Colorectal Cancer (CRC)1
  • Leukemia1

Other2 trials

HVA vs IA/DA or VA in the Treatment of ND HR-AML
Phase 3
Second-line Standard Treatment Sequential TAS-102 and Bevacizumab Combined With Local Treatment in Advanced Colorectal Cancer
Phase 2

Chicago, Illinois1 trial

Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL

University of Chicago

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.